The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia
Abstract
The dementia associated with human immunodeficiency virus (HIV) is poorly understood. Dementia is accompanied by infection and activation of macrophage lineage cells in the brain and production of toxic products by these cells has been postulated to play a role in the pathogenesis of dementia. Eicosanoids are potential products of activated macrophages that can mediate cell injury. We measured the levels of prostaglandin E 2 in the cerebrospinal fluid of HIV‐positive individuals with dementia and/or myelopathy and compared these levels with those of HIV‐negative patients with other neurological diseases and HIV‐positive patients without dementia. Cerebrospinal fluid prostaglandin E 2 levels were increased in dementia. This increase was associated with severity of dementia and correlated with cerebrospinal fluid levels of neopterin and β 2‐microglobulin. Prostaglandins F 2α and thromboxane B 2, additional products of the cyclooxygenase pathway of arachidonic acid metabolism, were also elevated in dementia, but leukotriene C 4, a product of the lipoxygenase pathway was not. Since synthesis of prostaglandins is regulated in part by the levels of inducible forms of cyclooxygenase, we measured the levels of cyclooxygenase‐1 and 2 mRNAs in the brains of HIV‐positive individuals with and without dementia by reverse transcriptase polymerase chain reaction. Levels of intact cyclooxygenase‐1 mRNA were higher in the brains of demented individuals, but this did not reach statistical significance. These data demonstrate that prostaglandins are increased in the central nervous system in HIV‐associated dementia and may play a role in the development of neurological dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of sleep‐wake regulation: roles of prostaglandins D 2 and E 2
Hayaishi, O. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907936 · Cited by 235
Cited by
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Microglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 567
Dementia Associated with the Acquired Immunodeficiency Syndrome
Lipton, S. A., & Gendelman, H. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321407 · Cited by 465
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Metadata
- Authors
- Griffin, D. E., Wesselingh, S. L., & McArthur, J. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1994-05
- Volume
- 35
- Issue
- 5
- Pages
- 592-597
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2008373701
- Cited by
- 225
- References
- 1
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia. https://app.cochat.ai/papers/10.1002/ana.410350513
- The paper
- Griffin, D. E., Wesselingh, S. L., & McArthur, J. C. (1994). Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia. Annals of Neurology. https://doi.org/10.1002/ana.410350513
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.